Coronary artery disease in the absence of traditional risk factors: a call for action
Suzanne Avis, Stephen T. Vernon, Emil Hagström, Gemma A. Figtree
Abstract
We examined the 256 clinical trials underpinning the two current international ST-elevation myocardial infarction (ST EMI) management guidelines to ascertain the proportion of trials that reported patients with no standard modifiable risk factors as a separate group. We examined the 256 clinical trials underpinning the two current international ST-elevation myocardial infarction (ST EMI) management guidelines to ascertain the proportion of trials that reported patients with no standard modifiable risk factors as a separate group.
Topics & Concepts
MedicineMyocardial infarctionClinical trialUnderpinningCoronary artery diseaseInternal medicineCall to actionCardiologyPhysical therapyCivil engineeringBusinessEngineeringMarketingAcute Myocardial Infarction ResearchCardiac Imaging and DiagnosticsHealth Systems, Economic Evaluations, Quality of Life